1.5-year clinical outcomes in patients with triple-mutated AML who were positive and negative for MRD before allo-HSCT. This paper explores the clinical outcomes of allogeneic hematopoietic stem cell ...
Bryn Ailinger had a rare mutation that made her leukemia less responsive to tradition treatment. But CAR T-Cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback